The current valuation score of Pulmatrix Inc is 7.15, ranking 261 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.33, which is -70.56% below the recent high of -0.39 and -187.53% above the recent low of -3.83.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.